Abiopharma

🔍 Stat Lauren Elaina Friedman (Director)

Company: Palantir Technologies Inc. (PLTR)

Report Date: 2026-05-29

Detailed Transactions and Holdings:

• Sold 1,667 shares of Class A Common Stock at $150.0 per share (Direct)
  Date: 2026-05-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 56,620.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,598 shares of Class A Common Stock at $160.0 per share (Direct)
  Date: 2026-06-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 55,022.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-05-29 | Code: H | nature_of_ownership: By spouse | shares_owned_after: 43,794.00
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-05-29 | Code: H | nature_of_ownership: By child's 2025 gift trust | shares_owned_after: 7,335.00 | Footnotes: F2

Footnotes:

• F1: The Reporting Person sold shares of Class A Common Stock in the open market pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), entered into on February 11, 2026.
• F2: These shares are held of record by the Reporting Person's spouse's child's 2025 gift trust, of which the Reporting Person serves as trustee.
• REMARKS: This Form 4 has been compiled based on applicable requirements to reflect the specific transactions described herein and is not intended to disclose or describe all shares and/or other equity securities owned or beneficially held by the Reporting Person. For additional details regarding the Reporting Person's overall stock and equity holdings, please see the Issuer's Proxy Statement filed with the Securities and Exchange Commission on April 24, 2026, including under the heading "Security Ownership Of Certain Beneficial Owners And Management" (subject to the definitions, explanations, and time periods described therein).